林 聖閎

Medicine & Life Sciences

1. Autoimmune Diseases 100%
2. Sjogren's Syndrome 86%
3. C1 peptide 77%
4. Systemic Lupus Erythematosus 66%
5. 2-nonenal 65%
6. Thyroiditis 58%
7. 4-hydroxy-2-nonenal 58%
8. Bisphosphonate-Associated Osteonecrosis of the Jaw 57%
9. RNA Editing 53%
10. Rheumatoid Arthritis 49%
11. Thymectomy 49%
12. Peptides 49%
13. Pneumocystis Pneumonia 47%
14. Rheumatic Diseases 45%
15. Histamine Antagonists 44%
16. Autoantibodies 44%
17. Proton Pump Inhibitors 43%
18. Autoimmune Haemolytic Anaemia 42%
19. Acetylation 40%
20. Immunoglobulin M 39%
21. Hepatitis B virus 37%
22. Cohort Studies 37%
23. Immunoglobulin A 36%
24. Hepacivirus 35%
25. Glioma 35%
26. Population 34%
27. Virus Diseases 33%
28. Fatty Acids 32%
29. Immunoglobulin G 31%
30. Hepatocellular Carcinoma 31%
31. anti-IgM 29%
32. Odds Ratio 29%
33. Systemic Vasculitis 27%
34. Lymphocytes 26%
35. Inflammation 26%
36. Taiwan 25%
37. Proportional Hazards Models 24%
38. Messenger RNA 21%
39. Myasthenia Gravis 21%
40. Ankylosing Spondylitis 20%
41. Serum 19%
42. Addison Disease 17%
43. National Health Programs 16%
44. Dermatomyositis 15%
45. Digestion 14%
46. Proteins 14%
47. Systemic Scleroderma 13%
48. anti-IgA 13%
49. Multivariate Analysis 13%
50. Atlases 12%